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Athyrium multidentatum (Doll.) 
Ching extract induce apoptosis 
via mitochondrial dysfunction and 
oxidative stress in HepG2 cells
Guoyuan Qi1, Zhigang Liu1, Rong Fan2, Ziru Yin3, Yashi Mi1, Bo Ren1 & Xuebo Liu1
Athyrium multidentatum (Doll.) Ching (AMC), a unique and nutritious potherb widely distributed in 
china, has been extensively used in traditional Chinese medicine. Previous studies indicated that 
AMC extract exhibited antioxidant and antitumor properties. However, the chemical composition of 
AMC and molecular mechanism of AMC toxicity to HepG2 cells have not yet been elucidated. Hence, 
this study aimed to investigate the chemical compositions and the underlying mechanisms of the 
antiproliferative and apoptotic effects of AMC on HepG2. HPLC-MS analysis showed that AMC contain 
five compounds with chlorogenic acid accounting for 43 percent. Also, AMC strongly inhibited the cell 
growth and induced apoptosis and cell cycle arrest in HepG2 cells by significantly upregulating the 
protein expressions of Fas, Fas-L, Bax/Bcl-2, cyto-c, cleaved caspase-3, and PARP in a dose-dependent 
manner, which indicates AMC induces apoptosis in HepG2 cells through both intrinsic and extrinsic 
pathways. Moreover, AMC provoked the production of ROS, H2O2, and NO, modulating the PI3K/Akt, 
MAPK, NFκB and Nrf2 pathways and their downstream transcriptional cascades, ultimately evoked 
oxidative stress and apoptosis in HpeG2 cells. Further in vivo experiments demonstrated that AMC 
significantly suppressed the tumor growth, suggesting that AMC may be a novel promising agent for 
hepatocellular carcinoma treatment.
Hepatocellular carcinoma (HCC), the predominant primary liver cancer, is the fifth most frequent cancer world-
wide and the second most common cause of cancer death in the world1, 2. However, Chemotherapy, as one of the 
cancer therapeutic methods, possesses side effects despite the significant advances in treatment of hepatocellular 
carcinoma3. Therefore, the development of an effective cancer chemotherapeutic agent with fewer side effects has 
been an urgent need for treatment of hepatocellular carcinoma. Apoptosis is a programmed cell death, which is 
critical in both normal development and maintenance of body homeostasis. Therefore, the induction of apoptosis 
will be a possible effective approach to alleviate hepatocellular carcinoma4.
It has been identified that apoptosis is associated with two major routes, including the cell death 
receptor-mediated extrinsic pathway and the mitochondria-mediated intrinsic pathway5. Particularly, 
the mitochondrial pathway mainly participates in phytochemicals-induced cancer cells apoptosis6. The 
mitochondrial-mediated apoptotic pathway begins with mitochondrial membrane potential loss, cytochrome c 
release, the executioner caspase-3 cleavage, and eventually resulting in the formation of apoptotic bodies. Also, 
the activation of mitogen protein kinases (MAPK) is involved in apoptosis processes. There are three major 
MAPK pathways in the extracellular signal-regulated kinases: ERK1/2 (p44/p42), c-Jun amino-terminal kinase 
JNK (p46/p54) and p38 kinase. In addition, the PI3K/Akt signaling pathway also plays a crucial role in carcino-
genesis and tumor progression by inhibition of apoptosis and promoting cell proliferation7.
Natural phytochemicals are considered as good sources of potential cancer chemopreventive and chemo-
therapeutic agents. Pharmaceuticals derived from plants have played an important role in the health care in both 
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ancient and modern times. Recently, great attention has been paid to the highly effective phytochemical antioxi-
dants and agents from natural sources8.
Athyrium multidentatum (Doll.) Ching (AMC) is a common fern species in northeast China, especially the 
Changbai Mountain area. The potential utilization of AMC as medicine has been documented in traditional 
Chinese medicine as a tranquilizer, antihypertensive, and diuretic9–11. Liu et al. reported that all fractions of pol-
ysaccharides extracted from AMC possessed considerable antioxidant activity12. Sheng et al. assessed antioxidant 
activity of degraded polysaccharides from AMC and found all four low molecular polysaccharides exhibited anti-
oxidant activity in vitro systems13. Our previous research demonstrated that AMC was a quality nutrition source 
for proteins, carbohydrates, fat, and minerals. AMC extracts possessed a strong antioxidant activity, protective 
effects on biomolecules, cellular antioxidant activity (CAA), and anti-proliferative effects owing to its highest total 
phenolic (476.52 ± 11.26 mg GAE per gram extract) and total flavonoid (924.81 ± 4.25 mg RNE per gram extract) 
contents. Furthermore, AMC extracts exhibited a promising effect on the inhibition of cell proliferation and 
stimulated apoptosis in HepG2 cancer cells10. However, the underlying molecular mechanisms of AMC-induced 
apoptosis in HepG2 cells remain elusive.
In this study, we aimed to investigate the anticancer effects of AMC on human hepatocellular carcinoma 
HepG2 cells and the underlying molecular mechanisms. AMC has been proved to induce HepG2 cell apoptosis 
via the death receptor-mediated extrinsic pathway and mitochondria-mediated intrinsic pathway. AMC triggered 
cancer cell death via apoptosis-related PI3K/Akt, MAPK, and p53 pathways. Furthermore, the nuclear translo-
cation of NFκB and Nrf2 oxidative stress-dependent pathways were also involved in AMC-induced apoptosis in 
HepG2 cells. Additionally, AMC administration induced G2/M phase cell cycle arrest by manifesting decreased 
cell-cycle related protein expressions of CDK1, CDK2, and Cyclin D1. AMC also displayed significant inhibitory 
effects on tumor size in vivo. Taken together, our results indicated that AMC triggers apoptosis via mitochondrial 
dysfunction and oxidative stress in HepG2 cells, significantly impeding tumor growth, and may provide a new 
strategy for dietary interventions of hepatocellular carcinoma patients.
Results
Identification and quantification of compounds of AMC. HPLC chromatograms exhibited that the 
five major peaks of the AMC had retention time of 22.976 min (Peak 1), 24.652 min (Peak 2), 33.758 min (Peak 
3), 38.133 min (Peak 4), 44.019 min (Peak 5). The Peak1 had the same retention time with that of chlorogenic 
acid in HPLC experiments (RT = 22.934 min) (Fig. 1A and B), which accounted for 43 ± 0.99% of AMC. Next, 
HPLC-MS was performed to confirm and determine that chlorogenic acid presence and the molecular formula of 
other compounds in AMC. Table 1 displayed their retention times, formula, wavelengths of maximum absorption 
in the visible region, mass spectral data and molecular formula. Peak 1(RT = 22.934), with [M-H]+ at 355, MS2 
fragment at m/z 163, was tentatively identified as chlorogenic acid. Peak 2 presented the same pseudomolecular 
ion [M-H]+ at m/z 355 and MS2 fragmentation patterns with peak1 was tentatively identified as an isomer of 
chlorogenic acid. Peak 3 presented a pseudomolecular ion [M-H]+ at m/z 451, releasing an MS2 fragment at m/z 
289, loss of a hexosyl moiety which was consistent with eriodictyol O-hexoside, although the nature and position 
of the sugar residue could not be established. From the ESI+ ion mode we found that decarboxylation reaction 
happened in Peak 5, suggesting that this compounds contained carboxyl. Therefore, peak 5 was temporarily iden-
tified as a caffeic acid amide, N-caffeoyl-phenylalanine. Nevertheless, peak 4 (RT = 38.133 min, λmax = 282 nm, 
[M-H]+ at m/z 435) remained unidentified.
Effect of AMC on HepG2 cells viability. The MTT assay was performed to evaluate the effect of AMC on 
cell proliferation of HepG2 cancer cells. As shown in Fig. 1C, treatments of 50, 100, and 200 μg/mL AMC for 24 h 
decreased the HepG2 cells viability to 84.5%, 68.3%, and 59.6%, respectively. After being incubated for 48 h, the 
cell viability was decreased to 67.09%, 42.92%, and 25.72%, respectively. The IC50 values of AMC on HepG2 cells 
were 220.32 ± 10.32 μg/mL after 24 h and 113.51 ± 7.45 μg/mL after 48 h. To investigate the cytotoxicity in normal 
cells, the same concentration of AMC treatment was performed on human liver cells HL7702 for 24 h and 48 h, 
respectively (Fig. 1D). AMC had no significant toxic effects on the viability of HL7702 cells, which illustrated the 
experimental conditions in this study had no toxicity to normal human liver cells. The IC50 values of AMC on 
HL7702 cells were 332.25 ± 15.17 μg/mL after 24 h and 303.98 ± 20.68 μg/mL after 48 h. To further determine the 
impacts of AMC on cancer cell growth, the colony formation assay was conducted on HepG2 cells (Fig. 1E and F). 
AMC showed potent and dose-dependent inhibition effects on the colony formation of HepG2 cells even after 
treated for 1 h or 2 h.
AMC elicited extrinsic and intrinsic apoptosis in HepG2 Cells. To confirm the effects of AMC treat-
ment on apoptosis, HepG2 cells were stained with Annexin V-FITC/PI, and subsequently analyzed by flow 
cytometer. Results implied that the early apoptosis rate increased in a time-dependent manner after AMC treat-
ment (Fig. 2A), suggesting that AMC can induce apoptosis in HepG2 cells.
The extrinsic pathway of apoptosis is initiated by death ligands, such as Fas-ligand (Fas-L), leading to cleavage 
of procaspase-8 to its active form. As shown in Fig. 2B, the expression of Fas and its ligand Fas-L was observed 
upon after treatment with various concentrations of AMC for 24 h. In addition, it was also found that AMC sig-
nificantly decreased the expression level of procaspase-8 and increased cleaved caspase-8 protein expression in 
the cytosol.
Mitochondria play a pivotal role in the intrinsic pathway of apoptosis14. Previous studies demonstrated that 
AMC could substantially suppress mitochondria membrane potential (MMP)10. As the early stage of intrinsic 
apoptosis, loss of MMP could induce cytochrome c releasing into cytosol from mitochondria membrane and 
activating caspase cascade and PARP cleavage. We investigated whether AMC can induce cytochrome c release 
from mitochondria by influencing the translocation of Bax, a key protein in the induction of cell apoptosis. 
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As shown in Fig. 2C, an increase of cytochrome c in the cytosol and a decrease of mitochondrial cytochrome c 
levels were detected after 24 h of exposure to various concentrations of AMC, compared with the control group. 
AMC also suppressed the expression level of apoptotic protein (Bcl-2) and triggered the translocation of Bax from 
cytoplasm to mitochondria, and the Bcl-2/Mito-Bax ratio gradually decreased in a concentration-dependent 
manner. We further confirmed whether Bax translocation from the cytoplasm to the mitochondria and 
cytochrome c release from mitochondria induced the caspase pathway. As shown in Fig. 2C, the expression levels 
of cleaved caspase-3 and the cleavage of PARP were increased in a dose-dependent manner after treatment with 
AMC for 24 h. These results suggested that AMC-induced apoptosis in HepG2 cells was activated through the 
death receptor-mediated extrinsic pathway and mitochondria-mediated intrinsic apoptotic pathway.
AMC induced oxidative stress in HepG2 cells. The cytotoxic effect of AMC was hypothesized to be 
related with oxidative stress. To confirm and quantify the oxidative stress triggered by AMC in HepG2 cells, the 
production of ROS and H2O2 was measured by DCFH-DA method and Hydrogen peroxide assay kit. As shown in 
Figure 1. Composition analysis and effect of AMC on cells viability and clonogenicity. HPLC chromatogram 
(obtained at 280 nm) of Athyrium multidentatum (Doll.) Ching extract (AMC) (1509 μg/mL) (A) and standard 
Chlorogenic acid (160 μg/mL) (B). HepG2 (C) and HL7702 (D) cell viability was assessed by MTT assay after 
treated with various concentrations of AMC for 24 h or 48 h. HepG2 cells were seeded in six-well plates. After 
24 h of incubation, cells were treated with various concentrations of AMC for 1 h (E) or 2 h (F) and subsequently 
allowed to grow into colonies for 10 days. The results are presented as mean ± SD, n ≥ 6 wells per group, 
*p < 0.05 and **p < 0.01 versus the control group.
www.nature.com/scientificreports/
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Fig. 3, AMC significantly increased the production of ROS and H2O2 of HepG2 cells in a dose-dependent manner. 
In addition, AMC dose-dependently reduced the expression of Complex I (Fig. 3D).
AMC induced apoptosis via mediating PI3K/Akt and MAPK pathways. PI3K/Akt is a potential sur-
vival signaling pathway involved in the regulation of the cell cycle, growth, survival, metabolism, and tumorigen-
esis15, 16. To evaluate the effect of AMC on PI3K/Akt pathway in HepG2 cells, the p-Akt and Akt were detected by 
western blot assays. When treated with 100 or 200 μg/mL of AMC, the amount of p-Akt significantly decreased, 
compared with control (p < 0.01). However, the expression of total Akt was not affected (Fig. 3E). In comparison 
to the control group, PI3K/Akt inhibitor LY294002 significantly increased cleaved caspase-3 and PARP cleavage 
in both the presence and absence of AMC (Supplementary Fig. E).
Accumulating evidence indicated that MAPK signaling pathway, the most extensively investigated molecular 
pathway in human cancer, is associated with apoptosis. In order to investigate whether MAPK signal pathway was 
involved in AMC induced cell apoptosis, the protein expressions of phosphorylated MAPK (ERK1/2, JNK and 
p38) were detected. From Fig. 3F, AMC significantly restrained the phosphorylation of ERK1/2, and increased the 
expressions of p-JNK and p-p38 in a dose-dependent manner, while the total ERK1/2, JNK and p38 protein levels 
Figure 2. AMC elicited extrinsic and intrinsic apoptosis in HepG2 Cells. Cells were incubated with AMC 
at indicated concentration for 24 h before tests were performed. Apoptotic cells detected by flow cytometry 
with annexin V conjugated with PI staining. (A) The Fas, Fas-L, procaspase-8 (B), Bcl-2, Bax, Cyto-c, Cleaved 
Caspase-3 and PARP. (C) expressions of the HepG2 cells were analyzed by western blot. The data were shown as 
the mean ± SD (n = 3). *p < 0.05 and **p < 0.01 versus the control group.
www.nature.com/scientificreports/
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Figure 3. Effect of oxidative stress, PI3K/Akt, and MAPK pathways on AMC induced apoptosis in HepG2 
cells. Cells were exposed to AMC (50, 100 and 200 μg/mL) for 24 h followed by incubation with DCFH-DA 
at 37 °C for 30 min and then detected by a fluorescence microscope (A). The ratio of fluorescence intensity 
(B) was obtained using Multimode plate readers. H2O2 was measured, after cells were incubated with variable 
concentrations of AMC for 24 h (C). Protein expression of Complex-I (D), Akt, p-Akt (E) p-p38, p38, p-JNK, 
JNK, p-ERK1/2, and ERK1/2 (F) were analyzed by western blot. Values are means ± SD for at least three 
independent experiments performed in triplicate. *p < 0.05 and **p < 0.01 versus the control group.
www.nature.com/scientificreports/
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remained constant throughout the process of AMC treatment. As shown in Supplementary Fig. B and C, both the 
JNK inhibitor SP600125 and the p38 inhibitor SB203580 increased cleaved caspase-3 levels and PARP cleavage 
levels respectively and in the presence of AMC. In addition, the ERK inhibitor U0126 markedly increased cleaved 
caspase-3 levels and PARP cleavage in the absence of ISO and promoted the activation effects of AMC on those 
protein levels (Supplementary Fig. D). Taken together, these results indicated that AMC induced apoptosis in 
HepG2 cells through PI3K/Akt and MAPK pathways.
Effect of NFκB and p53 signaling pathways on AMC induced apoptosis. Nuclear factor-κB 
(NFκB) is a transcription factor involved in cell survival, adhesion, inflammation, differentiation, and growth17. 
This study also discussed whether NFκB signaling pathway was involved in AMC-induced apoptosis of human 
hepatocellular carcinoma HepG2 cells. As shown in Fig. 4A, after treated with various concentrations (0, 50, 100, 
200 μg/mL) of AMC for 24 h, the AMC groups cells displayed a significant decrease protein expression levels of 
p-IκB and NFκB in nucleus, while the protein expression of NFκB in cytosol remarkably increased. Additionally, 
the NFκB inhibitor pyrrolidinedithiocarbamic acid (PDTC) significantly increased cleaved caspase-3 expression 
and PARP cleavage in the absence of AMC and promoted the activation effects of AMC on those protein levels 
(Supplementary Fig. F). These results confirmed that NFκB signaling pathway was involved in AMC-induced 
apoptosis of HepG2 cells. Furthermore, expressions of iNOS, p53, and NO were markedly up-regulated, whereas 
COX-2 was decreased after AMC treatment for 24 h in HepG2 cells (Fig. 4B and C).
Effects of AMC on the Keap1/Nrf2 transcriptional pathway. To investigate whether Nrf2-dependent 
antioxidant defense mechanism was activated during AMC-induced oxidative stress mediated cytotoxicity in 
HepG2 cells, we examined the Nrf2 nuclear translocation and the protein expressions of HO-1 and NQO-1. As 
shown in Fig. 4D, compared with the control group, AMC significantly inhibited the nuclear translocation of 
Nrf2 and expression of Keap1 in HepG2 cells. Furthermore, the results showed that AMC decreased the protein 
expression of HO-1 and NQO-1 in a dose-dependent manner in HepG2 cells (Fig. 4E).
Effect of AMC on cell cycle controlling of HepG2 cells. Apoptosis and cell cycle arrest are two main 
mechanisms for cell growth inhibition. The cell cycle distribution was investigated by flow cytometry flow on 
HepG2 cells with or without treatment with AMC for 24 h. As shown in Fig. 5A, the AMC treatment resulted in 
an increase in the percentage of cells in the G2/M phase in a concentration-dependent manner. In light of the 
above finding of G2/M arrest of cells after AMC exposure, expression levels of a series of regulatory proteins 
related to cell cycle were examined in HepG2 cells. Protein expressions of CDK1, CDK2 and Cyclin D1 were both 
markedly decreased (Fig. 5B). Overall, these data suggested that AMC could induce cell cycle arrest in G2/M 
phase associated with decreases of CDK1, CDK2 and Cyclin D1.
AMC attenuated tumor growth in vivo. To further evaluate whether AMC has an effect to inhibit tumor 
growth in vivo, we measured the tumor volume in a xenograft tumor model in which HepG2 cells were injected 
subcutaneously into nude mice. AMC (25 or 100 mg/kg) were selected for in vivo experiments. When transplant 
tumors reached a mean group size of approximately 100 mm3 (the thirteenth day), mice were treated with AMC 
every day for 31 days. Results clearly indicated that compared with the control group, AMC showed a significant 
inhibitory effect on tumor size (Fig. 6A and B). Caspase-3 and Ki-67 staining confirmed an increased apoptosis 
and a reduction in proliferative cells in AMC treated tumor animals in comparison to the untreated control 
(Fig. 6C).
Disscussion
Hepatocellular carcinoma (HCC) is a chronic disease affecting millions of humans18. However, the conventional 
therapies are not effective enough to treat patients of HCC. Therefore, it is imperative to find novel and effec-
tive strategies with low toxicity for the treatment of HCC. In recent years, Traditional medicinal plants pos-
sessing chemotherapeutic and chemopreventive properties have been investigated for their possible clinical 
application in the prevention and treatment of cancer and minimal side effects19–21. Extracts isolated from Korean 
Lonicera japonica Thunb., mulberry, Tetrastigma hemsleyanum, and Costus speciosus all displayed a promising 
pro-apoptosis effect on HepG2 cancer cells22–24.
AMC is a unique and nutritious potherb in Changbai Mountain area and widely used as an effective folk med-
icine for conditions such as high blood pressure, anxiety and arthritis12, 13. Our previous studies demonstrated 
that AMC exhibited excellent antioxidant activity, anti-proliferative, and pro-apoptotic properties on HepG2 
cells. Nevertheless, the underlying molecular mechanisms remain elusive. In this study, we further evaluated 
Compound RT (minutes) λmax (nm) MS+ (m/z)
MS2 fragment ions 
(m/z)
Molecular 
Formula
1 22.976 216, 325 355 163 C16H18O9
2 24.652 325 355 163 C16H18O9
3 33.758 283 451 289 C21H22O11
4 38.133 214, 282 435 273 C21H22O10
5 44.019 217, 277 328 103, 131, 152, 282 C18H17NO5
Table1. Retention times (RT), wavelengths of maximum absorption in the visible region (λmax), mass spectral 
data and molecular formula of the substances in AMC.
www.nature.com/scientificreports/
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Figure 4. AMC induced apoptosis via NFκB, p53, and Nrf2 related signaling pathways in in HepG2 cells. Cells 
were incubated with AMC at indicated concentration for 24 h before tests were performed. Protein expression 
of the NFκB signaling pathway (A), iNOS, COX-2, p53 (B), Nrf2 signaling pathway (D), HO-1, and NQO-1 (E) 
were analyzed by western blot. GAPDH and lamin B were used as internal controls. Nitrite (a stable end product 
of NO) present in culture medium was detected by the Griess reaction (C). Values were presented as mean ± SD 
for at least three independent experiments performed in triplicate. *p < 0.05 and **p < 0.01 versus the control 
group.
www.nature.com/scientificreports/
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the anticancer effect of AMC in HepG2 cells. HPLC and HPLC-MS were performed to identify and quantify of 
compounds of the AMC. Five major components were detected in AMC, among which chlorogenic acid (Peak 1) 
accounted for 43% (Fig. 1A and B). We noticed that AMC significantly inhibited cellular growth of HepG2 in a 
dose-dependent manner after 24 h or 48 h treatment but revealed no obvious toxicity to HL7702 cells identified by 
MTT assay (Fig. 2C and D). The mechanism of differential toxic effects on cancer and normal cells is still need to 
be further explored. To further elucidate the role of AMC in vivo, a HepG2 tumor model in Balb/c nu/nu mice was 
established. Significant tumor suppression by AMC at concentration of 100 mg/kg was observed (Fig. 6A and B).
Apoptosis, a programmed cell death mediated through the death receptor-mediated extrinsic pathway and 
the mitochondrial-mediated intrinsic pathway, has been evaluated as a major mechanism to eliminate can-
cer cells25. The extrinsic apoptotic pathway is triggered by binding of Fas with its extracellular ligand, Fas-L26. 
Consequently, the Fas/Fas-L protein complex activates its procaspase-8, which proceeds to trigger procaspase-3, 
the vital enzyme for execution of the apoptotic process27. Our results revealed that AMC significantly promoted 
Fas and Fas-L expression level and inhibited procaspse-8 expression level in a concentration-dependent manner 
(Fig. 2B). These results indicated that HepG2 cells treated with AMC were subjected to apoptosis involving death 
receptor-mediated extrinsic pathway.
Activation of mitochondria-mediated intrinsic apoptotic pathway is also a key mechanism involved in the 
function of anti-tumor drugs. Mitochondria play a critical role in the regulation of various apoptotic processes, 
including drug-induced apoptosis28. Bcl-2 family members, such as pro-apoptotic protein Bax and anti-apoptotic 
protein Bcl-2 are critical regulators of the mitochondrial pathway29, 30. They can modulate the mitochondrial 
outer membrane permeability to control the release of mitochondrial cytochrome c31. In line with those findings, 
our study found that AMC significantly increased the translocation of Bax from cytoplasm to mitochondria and 
cytochrome c release from mitochondria in HepG2 cells (Fig. 2C). These processes led to the activation of the 
Figure 5. Effect of AMC on cell cycle arrest of HepG2 cells. Representative flow cytomeric analysis for the 
DNA content in HepG2 cells treated with AMC at different concentrations of 50 μg/mL, 100 μg/mL, and 200 μg/
mL. Cell cycle distribution and cell number percentage in each phase (G0/G1, S, and G2/M) were detected 
and calculated (A). The protein expression of CDK1, CDK2, and Cyclin D1 were analyzed by western blot 
(B). Values were presented as mean ± SD for at least three independent experiments performed in triplicate. 
*p < 0.05 and **p < 0.01 versus the control group.
www.nature.com/scientificreports/
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executioner caspases-3, and ultimately the inactivation of PARP. These data indicated that the mitochondrial 
pathway was involved in AMC-induced apoptosis.
ROS is an important intracellular signal of cell proliferation. Once intracellular ROS levels are too high, per-
oxidation damage and apoptosis will occur32. Various plant polyphenols exert their anticancer effects through 
inducing the generation of ROS25, 32. H2O2, a second messenger generated from mitochondria, regulates multiple 
cell signaling pathways and a range of cell functions such as inflammatory, apoptosis, and energy metabolism33. 
H2O2 acts as an efficient redox molecule since it can easily pass through the mitochondrial membranes and 
diffuse to other mitochondria34. AMC induced mitochondrial dysfunction and improved intracellular ROS and 
H2O2 production, thus increased oxidative stress in HepG2 cells (Fig. 3A–C). Complex I was generally consid-
ered a major site of ROS production where electron leaked and single electrons reacted with oxygen, producing 
superoxide anion35. Complex I dysfunction had often been linked with alteration in ROS levels36. AMC treatment 
remarkably decreased the expression of complex I in HepG2 cells (Fig. 3D). These results supported the notion 
that AMC can induce mitochondrial dysfunction in HepG2 cells.
Accumulated evidence suggested that PI3K/Akt and MAPKs signaling pathways were related to cellular 
redox-sensitive. PI3K/Akt pathway is a target for treating various tumors because it regulates cells proliferation 
and apoptosis7. Akt is the central downstream molecule of PI3K and its phosphorylation has been considered 
as an important factor in the prohibition of cancer. Akt is also involved in maintenance of the bioenergetic and 
metabolic capacities of mitochondria. Suppression of the phosphorylation of Akt by AMC was consistent with 
the loss of mitochondrial function (Fig. 3E). MAPK signaling pathway members played important roles in the 
induction of apoptosis. Once activated, ERK played an essential role in anti-apoptotic activity, while JNK and p38 
were significant in pro-apoptotic activity37. Our results showed that AMC led to a decrease in phosphorylation of 
anti-apoptotic kinases ERK and an increase in phosphorylation of pro-apoptotic kinases JNK and p38, indicating 
that MAPKs signaling pathways were triggered to induce the apoptosis of HepG2 cells (Fig. 3F).
Figure 6. Growth inhibition of transplantable tumors by AMC in vivo. The average tumor volume calculated 
at the certain time points in HepG2-bearing Balb/c nu/nu mice (n = 5, per group) (A). *p < 0.05 and 
**p < 0.01 25 mg/kg AMC-treatment group versus the control group. #p < 0.05 and ##p < 0.01 100 mg/kg 
AMC-treatment group versus the control group. Tumors were isolated on day 44, tumors formed in each group 
were photographed and 2 representative tumors from 5 different mice are displayed (B). Values are presented 
as means ± SEM for at least three independent experiments performed in triplicate. Immuno staining was 
performed on paraffin embedded tissue sections for cleaved caspase-3 and Ki-67 using respective antibodies in 
control tumor tissues and AMC treated tumor tissues after 30th day of treatment. Final magnification shown 
is 200× (C). (D) The images of IHC were quantified by Image J and values were presented as mean ± SD for at 
least three independent experiments performed in triplicate. *p < 0.05 and **p < 0.01 versus the control group.
www.nature.com/scientificreports/
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It is well established that NFκB is a crucial transcription factor associated with several cancer types and con-
trols multiple genes involved in tumor progression such as cell proliferation and survival38. Mitochondria-derived 
H2O2 plays a crucial role in the activation of NFκB39. The tumor suppressor p53 is the key factor that maintains 
genomic stability by regulating the cell cycle and DNA repair process. P53 regulates the expression of inducible 
nitric oxide synthase (iNOS), which produces NO and promotes inflammation in tissues34. In present study, we 
found that AMC markedly increased p53 and iNOS levels and the protein expression of NFκB in the cytosol and 
decreased the level of NFκB in the nucleus which implied that AMC-induced apoptosis was associated with the 
NFκB pathway (Fig. 4A–C).
Nrf2 is a redox-sensitive transcription factor that plays a crucial role in modulating redox homeostasis and 
regulating inflammatory conditions through the induction of many stress responsive and cytoprotective enzymes 
and related proteins including HO-1 and NQO-1. Evidence accumulated during recent years suggests that HO-1 
plays important roles in rapid tumor growth through anti-oxidative and antiapoptotic effects40. In this study, 
AMC treatment significantly decreased the expression of Nrf2 in nucleus, and subsequently downregulated HO-1 
and NQO-1 levels in HepG2 cells (Fig. 4D and E). It has been reported that oxidants released from mitochondria 
can induce activation of Nrf2, leading Nrf2 to translocate into the nucleus and binding to the antioxidant response 
elements (ARE) of a range of phase II antioxidant defense genes34, 41. Moreover, activation of Nrf2 appears to be 
regulated by phosphorylation-signaling pathways, including MAPKs and PI3K42. In this study, we showed that 
AMC significantly suppressed ERK1/2 and Akt phosphorylation (Fig. 3E and F). These results suggested that Nrf2 
pathway partly account for AMC-induced apoptosis in HepG2 cells.
Cell cycle arrest is a key mechanism by which anticancer drugs exert their effect on cancer cells. In the present 
study, after a 24 h exposure to AMC, cells showed a statistically significant increase in the G2/M fraction (Fig. 5A). 
This result aligned with findings by other authors who indicated the increases of the number of cells in G2/M of 
the cycle are related to apoptosis43. Cyclins and CDKs play important roles in the progression of tumor-associated 
cell cycle defects44. Cyclin D1 was proved to be associated with an increased transcription, translation and pro-
tein stability of CDKs in cancer cells45. Whereas CDK1 participated in cell cycle progression by enhancing cell 
cycle distribution in the G2/M fraction. The results of western blot analysis displayed that AMC caused sus-
tained decreases in cell cycle related protein expressions of CDK1, CDK2 and Cyclin D1 in HepG2 cells (Fig. 5B). 
Numerous research studies have shown that p53 is associated with G2/M phase cell cycle arrest through the 
transcriptional activation of a CDK inhibitor, p2144, 46–48. p53 activation observed in this study may contribute to 
the reduction of CDK1 and CDK2, eventually leading to G2/M cell cycle arrest. Experimental results of xenograft 
tumor model and immunohistochemical (IHC) confirmed the data obtained in vitro to further emphasize the 
pro-apoptosis role of AMC in hepatocellular carcinoma (Fig. 6A–C).
In summary, our study was the first to identify the remarkable anticancer activity of AMC and offered a 
novel insight into the apoptotic mechanisms in hepatocellular carcinoma. It was demonstrated that AMC 
triggered apoptotic cell death in HepG2 cells through both intrinsic and extrinsic pathways via triggering 
mitochondrial-mediated H2O2 generation and regulating PI3K/Akt, MAPK, NFκB, Nrf2, and p53 pathways, ulti-
mately led to mitochondrial dysfunction and oxidative stress. Furthermore, AMC showed a potential inhibitory 
Figure 7. A schematic diagram of the proposed mechanisms of AMC-induced apoptosis in HepG2 cells.
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effect on tumor size in vivo. A schematic diagram of these observed effects of AMC is shown in Fig. 7. The results 
of this study may provide a new option for the diet of susceptible hepatocellular carcinoma susceptible patients.
Materials and Methods
Cell culture and AMC treatment. HepG2 cells were provided by Kunming Institute of Zoology, Chinese 
Academy of Sciences (Kunming, China) and cultured in Roswell Park Memorial Institute-1640 supplemented 
with 10% FBS, 100 IU/mL penicillin, and 100 μg/mL streptomycin at 37 °C in a humidified atmosphere with 5% 
CO2. For the AMC treatment, AMC was dissolved in DMSO to a stock solution of 100 mg/mL and further diluted 
to different concentrations with FBS-free culture medium.
Chemicals and reagents. For these experiments, 20, 70 - dichlorofluorescein diacetate (DCFH-DA), vita-
min C, and linoleic acid (LA) were purchased from Sigma (Shanghai, China). Fetal bovine serum (FBS) and 
RPMI-1640 cell culture media were purchased from Thermo Fisher (Shanghai, China). The primary antibodies 
against Poly (ADP-ribose) polymerase (PARP), procaspase-8, cleaved caspase-3,NFκB, p65, CDK1, Cyclin D1, 
CDK2, IκB, p-IκB, Fas, Bcl-2, Bax, Cyto-c, and ND1 antibodies were provided by Cell Signaling Technology 
(Shanghai, China). α-tublin, lamin B, β-actin, GAPDH, HO-1, NQO-1, iNOS, COX-2, p53, Nrf2, keap-1 were 
from Santa Cruz Biotechnology (Dallas, Texas, USA). Cell cycle kit and Annexin V/PI cell apoptosis kit were 
from Wanleibio Company (Shenyang, Liaoning, China). All other chemicals were of analytical grade and were 
produced in China.
Preparation of AMC. AMC was collected in Ji’an, Jilin province (China) from May 10th–16th, 2014. The 
bioactive components were extracted by the protocol from our previous report10.
HPLC and HPLC-MS analysis. The phenolic and flavonoids-richen extract of AMC was resolved in 50% 
methanol (HPLC grade), filtered through a 0.45 μm pore-size membrane. Separation was performed using HPLC 
apparatus (LC-10Avp plus, Shimadzu, Japan) equipped with a reverse-phase C18 column (250 mm × 4.6 mm, 
5 mm; Agilent, USA) and a UV detector at 280 nm. The mobile phase was solvent A (0.1% acetic acid in water) 
and solvent B (methanol) with a gradient elution: 0–5 min, B from 5–10%; 5–30 min, B from 10–40%; 30–50 min, 
B from 40–50%; 50–55 min, B from 50–98%; 55–56 min, B from 98–5% and maintained to 64 min. The flow rate 
was 1 mL/min, and the optical density of effluent was monitored at 280 nm.
For confirmatory purposes, high performance liquid chromatography (HPLC-MS) analysis was performed 
using HPLC system (Thermo scientific Ultimate 3000), coupled with a Mass Spectrometric Technology of Q 
Exactive (Thermo Fisher Scientific, Waltham, USA). AMC was separated by Thermo Scientific Hypersil GOLD 
C18 (100 × 2.1 mm, 1.9 μm) using flow rate at 0.3 mL/min at 35 °C. The mobile phase consisted of eluent A (0.05% 
formic acid) and eluent B (methanol) with a gradient elution: 0–2 min, 10% B; 2–8 min, B from 10% to 35%; 
8–14 min, B from 35% to 95% and maintained to 18 min; 18–20 min, B from 90% to 10%. The injection volume 
was set at 10 μL. The MS were set as following conditions: positive ion mode, Atomization at 350 °C, sheath gas 
pressure 30 arb, aux gas pressure 10 arb, and scan range m/z 100 to 1500.
Cell Viability Assay. HepG2 and HL7702 Cell viability was determined using the MTT assay. Cells were 
seeded in 96-well culture plates at a density of 2.5 × 104 cells per well with 5% (v/v) CO2 at 37 °C. After 12 h 
of incubation, the growth medium was replaced by mediums containing different concentrations of the AMC 
(0–200 μg/mL) and incubated for 24 h or 48 h. Then, cells were incubated with MTT (0.5 mg/mL) for 4 h. 
Subsequently, 100 μL of DMSO was added to each well to dissolve the formazan crystals. Absorbance at 490 nm 
was measured with a microplate reader (Bio-Rad, China). Cell viability was presented as a percentage of the con-
trol group (untreated cells).
Colony formation assay. Colony formation assays were performed as previously described with minor 
modifications. Cells were plated in 6-well plates at a concentration of 500 cells per well and were allowed to grow 
for overnight. Then, cells were incubated in the presence or absence of various concentrations (50, 100, 150, 
200 μg/mL) of AMC for 1 h or 2 h. The media containing AMC was then removed, and the cells were washed 
with PBS and incubated for an additional 10 days in a complete medium to form colonies. Subsequently, cells 
were washed twice with PBS, treated with crystal violet for 10 min, washed three times with H2O, and then pho-
tographed with a digital camera.
ROS, H2O2, and NO measurements. Cellular ROS was measured with DCFH-DA (dichlorodihydroflu-
orescein diacetate) which was employed to measure ROS production. Intracellular ROS in the presence of perox-
idase can change DCFH to the highly fluorescent compound DCF. Hence, the detection of DCF fluorescence can 
represent the level of active oxygen produced by cells. After various treatments, DCFH-DA was then added to a 
final concentration of 10 μM and incubated for 30 min at 37 °C. Relative fluorescence intensities were monitored 
by a Multimode plate reader (Tecan, Switzerland) 485 nm excitation and 535 nm emission and were qualitatively 
analyzed by fluorescence microscopy (Olympus Optical, Japan).
H2O2 generation from cells were carried out using Hydrogen peroxide assay kit following the manufacturer’s 
instructions (Beyotime Institute of Biotechnology, Jiangsu, China).
NO production was determined by measuring the amount of nitrite (a stable end product of NO) present in 
culture medium based on the Griess reaction47. The culture supernatant was incubated with the same volume of 
the Griess reagent (0.1% (w/v) N-(1-naphathyl)-ethylenediamine and 1% (w/v) sulfanilamide in 5% (v/v) phos-
phoric acid) for 10 min at 37 °C. The absorbance was measured at 540 nm using the UV-2550 ultraviolet photo-
metric scenery (Shimadzu, Japan). The amount of nitrite was calculated from a sodium nitrite standard curve.
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Flow cytometry assay. The distribution of cells in the different phases of the cell cycle was measured by 
the DNA content of nuclei labeled with propidium iodide (PI) according to the instructions of the manufacturer 
(Wanleibio, Shenyang, China). Briefly, 6 × 105 cells were plated in 60-mm dishes and grown overnight, treated 
with various concentrations of AMC (0, 50, 100, 200 μg/mL) for 24 h. After added trypsin, cells were fixed in 70% 
ethanol overnight at 4 °C, incubated in 100 μL RNase A at 37 °C for 30 min, and stained with 500 μl propidium 
iodide at 4 °C for 30 min. Cell cycle distribution was monitored with a FACSCalibur (BD Biosciences, USA) and 
analyzed using CellQuest software.
Early and late phases of apoptotic cells were monitored by Annexin V-FITC/PI apoptosis detection kit. After 
treatment, cells were washed twice with cold PBS, re-suspended in binding buffer, and incubated with FITC and 
PI staining solution following the instructions of the manufacture (Wanleibio, Shenyang, China). Samples of 
10,000 stained cells were analyzed by flow cytometry.
Proteins extraction. The proteins in whole cell were extracted using RIPA lysis buffer. Nuclear and cytoplas-
mic proteins were extracted by using a nuclear and cytoplasmic protein extraction kit (Beyotime, Jiangsu, China). 
Briefly, after treatment, cells were washed twice with PBS, scraped and collected by centrifugation at 1500 × g for 
5 min. Cell pellets were resuspended in 200 mL extraction buffer A and incubated for 15 min on ice. Afterwards, 
extraction buffer B was added, and samples were vortexed for 30 s at 4 °C. After centrifugation at 12000 × g for 
5 min at 4 °C, supernatants, which contained the cytosolic fractions, were removed and stored at −80 °C until ana-
lyzed by gel electrophoresis. Pellets, which contained the nuclei, were resuspended in 50 mL of nuclear extraction 
buffer, and nuclear proteins were extracted by shaking the samples for 30 min at 4 °C. Afterwards, samples were 
centrifuged at 12 000 × g for 5 min at 4 °C. The supernatants were removed and analyzed using gel electrophoresis. 
The validation of the method used to isolate the cytosolic and nuclear fractions (Lamin B was used as a loading 
control for nuclear proteins, and α-tubulin was used as the loading control for cytoplasm proteins) was checked 
using western blot analysis (Supplementary Fig. G). Bax translocation from the cytoplasm to the mitochondria 
and cytochrome c release from mitochondria were evaluated by western blot analysis of cytosolic protein sam-
ples. Cytosolic and mitochondrial protein fractions were also prepared using the cell mitochondria isolation kit 
(Beyotime, Jiangsu, China) according to the manufacturer’s instructions.
SDS-PAGE and western blot analysis. The SDS-PAGE analysis and western blot measurements were 
performed by previous reports from our lab49, 50.
Animals and xenografts. Five-week-old male Balb/c nu/nu mice were purchased from Model Animal 
Research Center of Nanjing University (Nanjing, China). All of the experimental procedures followed by Guide 
for the Care and Use of Laboratory Animals: Eighth Edition, ISBN-10: 0-309-15396-4, and the animal protocol 
was approved by the animal ethics committee of Xi’an Jiaotong University. All surgery was performed under 
anesthesia and all efforts were made to minimize suffering. The mice were implanted subcutaneously in their 
right flanks with suspended in PBS. Tumors were established by injecting 5 × 106 HepG2 cells into the right flank 
of Balb/c nu/nu mice. After tumor sizes reached approximately 100 mm3, mice were divided into two groups 
and intraperitoneal injection with saline or AMC at a dosage of 25 or 100 mg/kg for 30 days. The body weight of 
tumor-bearing mice was recorded every three days and tumor volume was calculated according to the formula 
ab2/2 (b is the smaller dimension of the two). Caspase-3 and Ki-67 staining was performed on AMC treated tis-
sues sections as described before48.
Statistical analysis. The data was representative of three independent experiments. The results were pre-
sented as the mean ± standard deviation (SD). Significant differences between measurements for the control and 
treated samples were analyzed using one-way factorial analysis of variance (ANOVA), followed by Tukey’s test 
(SPSS 16.0). A p < 0.05 was considered to indicate statistical significance.
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